These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15032786)

  • 1. Sample size calculations for surveys to substantiate freedom of populations from infectious agents.
    Johnson WO; Su CL; Gardner IA; Christensen R
    Biometrics; 2004 Mar; 60(1):165-71. PubMed ID: 15032786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A general approach to sample size determination for prevalence surveys that use dual test protocols.
    Cheng D; Stamey JD; Branscum AJ
    Biom J; 2007 Aug; 49(5):694-706. PubMed ID: 17722203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A stochastic simulation model to determine the sample size of repeated national surveys to document freedom from bovine herpesvirus 1 (BoHV-1) infection.
    Knopf L; Schwermer H; Stärk KD
    BMC Vet Res; 2007 May; 3():10. PubMed ID: 17511856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size determination for estimation of the accuracy of two conditionally independent tests in the absence of a gold standard.
    Georgiadis MP; Johnson WO; Gardner IA
    Prev Vet Med; 2005 Sep; 71(1-2):1-10. PubMed ID: 16076507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic test accuracy and prevalence inferences based on joint and sequential testing with finite population sampling.
    Su CL; Gardner IA; Johnson WO
    Stat Med; 2004 Jul; 23(14):2237-55. PubMed ID: 15236428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-based sample size calculation for consecutive surveys to document freedom from animal diseases.
    Schwermer H; Reding I; Hadorn DC
    Prev Vet Med; 2009 Dec; 92(4):366-72. PubMed ID: 19762100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exact alpha-error determination for two-stage sampling strategies to substantiate freedom from disease.
    Kopacka I; Hofrichter J; Fuchs K
    Prev Vet Med; 2013 May; 109(3-4):205-12. PubMed ID: 23103193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The choice of sample size: a mixed Bayesian / frequentist approach.
    Pezeshk H; Nematollahi N; Maroufy V; Gittins J
    Stat Methods Med Res; 2009 Apr; 18(2):183-94. PubMed ID: 18445695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poisson sampling: a sampling strategy for concurrently establishing freedom from disease and estimating population characteristics.
    Williams MS; Ebel ED; Wells SJ
    Prev Vet Med; 2009 May; 89(1-2):34-42. PubMed ID: 19217677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian sample size for diagnostic test studies in the absence of a gold standard: Comparing identifiable with non-identifiable models.
    Dendukuri N; Bélisle P; Joseph L
    Stat Med; 2010 Nov; 29(26):2688-97. PubMed ID: 20803558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials.
    Daimon T
    Contemp Clin Trials; 2008 Jul; 29(4):507-16. PubMed ID: 18201944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified exact sample size for a binomial proportion with special emphasis on diagnostic test parameter estimation.
    Fosgate GT
    Stat Med; 2005 Sep; 24(18):2857-66. PubMed ID: 16134167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian sample size determination for prevalence and diagnostic test studies in the absence of a gold standard test.
    Dendukuri N; Rahme E; Bélisle P; Joseph L
    Biometrics; 2004 Jun; 60(2):388-97. PubMed ID: 15180664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cluster-adjusted sample size algorithm for proportions was developed using a beta-binomial model.
    Fosgate GT
    J Clin Epidemiol; 2007 Mar; 60(3):250-5. PubMed ID: 17292018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sampling--how big a sample?
    Aitken CG
    J Forensic Sci; 1999 Jul; 44(4):750-60. PubMed ID: 10432610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sequential design to estimate sensitivity and specificity of a diagnostic or screening test.
    Wruck LM; Yiannoutsos CT; Hughes MD
    Stat Med; 2006 Oct; 25(20):3458-73. PubMed ID: 16374904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size calculation should be performed for design accuracy in diagnostic test studies.
    Flahault A; Cadilhac M; Thomas G
    J Clin Epidemiol; 2005 Aug; 58(8):859-62. PubMed ID: 16018921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bayesian, combinatorial approach to capture-recapture.
    García-Pelayo R
    Theor Popul Biol; 2006 Nov; 70(3):336-51. PubMed ID: 16904143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of diagnostic tests for estimating prevalence during surveillance programs].
    Fuchs K; Deutz A; Köfer J; Wagner P
    Berl Munch Tierarztl Wochenschr; 2000 Sep; 113(9):348-51. PubMed ID: 11042948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A general approach for sample size and power calculations based on the Haseman-Elston method.
    Hädicke O; Pahlke F; Ziegler A
    Biom J; 2008 Apr; 50(2):257-69. PubMed ID: 18383449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.